The IL−1 gene polymorphism may have a negative effect on the results of peri-implantitis treatment in genotype-positive individuals, and the combination of IL−1A (−889)/IL−1B (+3954) in peri-implant tissues may act as a risk factor that elevates tissue destruction [36]. The gene discussed is IL1B; the disease is Peri-Implantitis.